Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Enoxaparin Sodium

    Client Email Product

    Enoxaparin Sodium

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    28
    US DMFs Filed

    US DMFs Filed

    14
    CEP/COS Certifications

    CEP/COS Certifications

    3
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    1
    Other Suppliers

    Other Suppliers

    15
    API REF. PRICE (USD / KG)
    23,822

    API Market Place

    36
    INTERMEDIATES
    2
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    62
    Europe

    Europe

    50
    Canada

    Canada

    37
    Australia

    Australia

    26
    South Africa

    South Africa

    10
    Uploaded Dossiers

    Uploaded Dossiers

    65
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1,661.00

    Annual Reports

    1,655.00

    FDF Market Place

    67
    EXCIPIENTS
    3
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    31
    REF STANDARD

    EDQM

    1

    USP

    7

    JP

    0

    Other Listed Suppliers

    4
    SERVICES

    0

    left grey arrow
    right gray arrow
    • INJECTABLE;SUBCUTANEOUS - 100MG/ML (100MG/ML)
    • INJECTABLE;SUBCUTANEOUS - 120MG/0.8ML (150MG/ML)
    • INJECTABLE;SUBCUTANEOUS - 150MG/ML (150MG/ML)
    • INJECTABLE;INTRAVENOUS, SUBCUTANEOUS - 300MG/3ML (100MG/ML)
    • INJECTABLE;SUBCUTANEOUS - 30MG/0.3ML (100MG/ML)
    • INJECTABLE;SUBCUTANEOUS - 40MG/0.4ML (100MG/ML)
    • INJECTABLE;SUBCUTANEOUS - 60MG/0.6ML (100MG/ML)
    • INJECTABLE;SUBCUTANEOUS - 80MG/0.8ML (100MG/ML)
    • INJECTABLE;SUBCUTANEOUS - 90MG/0.6ML (150MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
    Full View ScreenFull Screen View
    Venus Remedies expands presence with marketing authorisation for enoxaparin
    Venus Remedies expands presence with marketing authorisation for enoxaparin

    https://www.indianpharmapost.com/news/venus-remedies-expands-global-presence-with-marketing-authorisation-for-enoxaparin-from-azerbaijan-15007

    INDIAN PHARMA POST
    13 Dec 2023
    Share Share
    Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia
    Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-marketing-approval-for-anticoagulant-drug-in-saudi-arabia/articleshow/103138194.cms

    ECONOMIC TIMES
    28 Aug 2023
    Share Share
    Techdow USA Announces Launch of its Generic Lovenox
    Techdow USA Announces Launch of its Generic Lovenox

    https://www.businesswire.com/news/home/20230608005338/en

    BUSINESSWIRE
    08 Jun 2023
    Share Share
    BE Pharms' Generic Enoxaparin Sodium Receives Approval in the U.S.
    BE Pharms' Generic Enoxaparin Sodium Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214646

    FDA
    06 Jun 2023
    Share Share
    Techdow USA Announces FDA Approval of Generic Lovenox
    Techdow USA Announces FDA Approval of Generic Lovenox

    https://www.businesswire.com/news/home/20230317005370/en

    BUSINESSWIRE
    20 Mar 2023
    Share Share
    Venus Remedies gets good manufacturing certification from Saudi drug regulator
    Venus Remedies gets good manufacturing certification from Saudi drug regulator

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-good-manufacturing-certification-from-saudi-drug-regulator/articleshow/98267076.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    27 Feb 2023
    Share Share
    Nanjing King Generic Enoxaparin Sodium Receives Approval in the U.S.
    Nanjing King Generic Enoxaparin Sodium Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214856

    FDA
    14 Jun 2022
    Share Share
    Heparin Crude, A Biological Material
    Heparin Crude, A Biological Material

    https://www.suanfarma.com/en/products/heparin-crude-a-biological-material/

    PRESS RELEASE
    05 May 2022
    Share Share
    DGFT imposes restriction on export of enoxaparin & i.v immunoglobulin
    DGFT imposes restriction on export of enoxaparin & i.v immunoglobulin

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145135&sid=1

    PHARMABIZ
    11 Jan 2022
    Share Share
    Enforcement Report - Week of December 08, 2021
    Enforcement Report - Week of December 08, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-08-2021-1638945311.pdf

    FDA
    08 Dec 2021
    Share Share
    Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL
    Sandoz, Inc. Issues Nationwide Recall of One Lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL

    https://www.pharmacompass.com/pdf/news/sandoz-inc-issues-nationwide-recall-of-one-lot-of-enoxaparin-sodium-injection-usp-40mg04-ml-1638766823.pdf

    FDA
    02 Dec 2021
    Share Share
    Oral milvexian reduces risk of postoperative venous thromboembolism
    Oral milvexian reduces risk of postoperative venous thromboembolism

    https://www.europeanpharmaceuticalreview.com/news/165579/oral-milvexian-reduces-risk-of-postoperative-venous-thromboembolism/

    Anna Begley EUROPEANPHARMACEUTICALREVIEW
    19 Nov 2021
    Share Share
    BMS, Janssen blood clot med aces proof-of-concept study
    BMS, Janssen blood clot med aces proof-of-concept study

    https://www.fiercebiotech.com/biotech/bristol-myers-janssen-look-to-phase-3-as-anticoagulant-med-aces-proof-concept-study

    FIERCEBIOTECH
    16 Nov 2021
    Share Share
    Enforcement Report - Week of February 17, 2021
    Enforcement Report - Week of February 17, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-17-2021-1613546616.pdf

    FDA
    17 Feb 2021
    Share Share
    Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection
    Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Injection

    https://www.pharmacompass.com/pdf/news/apotex-corp-issues-voluntary-nationwide-recall-of-enoxaparin-sodium-injection-1612588889.pdf

    FDA
    04 Feb 2021
    Share Share
    Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Inj, USP
    Apotex Corp. Issues Voluntary Nationwide Recall of Enoxaparin Sodium Inj, USP

    https://www.prnewswire.com/news-releases/apotex-corp-issues-voluntary-nationwide-recall-of-enoxaparin-sodium-injection-usp-due-to-mislabeling-of-syringe-barrel-measurement-markings-301220724.html

    PRNEWSWIRE
    02 Feb 2021
    Share Share
    NPPA asks cos to ensure adequate stock of enoxaparin injection in Chhattisgarh
    NPPA asks cos to ensure adequate stock of enoxaparin injection in Chhattisgarh

    http://www.pharmabiz.com/NewsDetails.aspx?aid=134075&sid=1

    PHARMABIZ
    11 Dec 2020
    Share Share
    Taiwan reports first COVID-19 patient recovery with eIND Silmitasertib treatment
    Taiwan reports first COVID-19 patient recovery with eIND Silmitasertib treatment

    https://www.biospectrumasia.com/news/39/16714/taiwan-reports-first-covid-19-patient-recovery-with-eind-silmitasertib-treatment.html

    BIOSPECTRUM ASIA
    15 Sep 2020
    Share Share
    Meitheal Pharma Announces Launch of Enoxaparin Sodium Injection
    Meitheal Pharma Announces Launch of Enoxaparin Sodium Injection

    https://www.businesswire.com/news/home/20200528005081/en

    BUSINESSWIRE
    28 May 2020
    Share Share
    Meitheal Pharmaceuticals Announces FDA Approval of Enoxaparin Sodium Injection
    Meitheal Pharmaceuticals Announces FDA Approval of Enoxaparin Sodium Injection

    https://www.businesswire.com/news/home/20191205005144/en

    BUSINESSWIRE
    05 Dec 2019
    Share Share
    China's Fosun rallies support for a joint bid for Bayer's animal health unit
    China's Fosun rallies support for a joint bid for Bayer's animal health unit

    https://www.fiercepharma.com/pharma-asia/china-s-fosun-rallies-support-for-a-joint-bid-for-bayer-s-animal-health-unit-report

    Angus Liu FIERCE PHARMA
    19 Jun 2019
    Share Share
    Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
    Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement

    https://www.fiercepharma.com/pharma/amphastar-squeezes-partners-momenta-sandoz-for-59-9m-lovenox-settlement

    Eric Sagonowsky FIERCE PHARMA
    19 Jun 2019
    Share Share
    AMAG Pharma to buy US-based biopharma company, Perosphere Pharmaceuticals
    AMAG Pharma to buy US-based biopharma company, Perosphere Pharmaceuticals

    http://www.pharmabiz.com/NewsDetails.aspx?aid=112886&sid=1

    PHARMABIZ
    14 Dec 2018
    Share Share
    Apotex's Generic Enoxaparin Sodium Receives Approval in US
    Apotex's Generic Enoxaparin Sodium Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078990

    FDA
    02 Oct 2018
    Share Share
    ESC: J&J hunts for silver lining as Xarelto bomb, heart failure studies
    ESC: J&J hunts for silver lining as Xarelto bomb, heart failure studies

    https://www.fiercepharma.com/marketing/esc-johnson-johnson-admits-double-xarelto-flop-blood-clot-heart-failure-studies

    Carly Helfand FIERCE PHARMA
    27 Aug 2018
    Share Share
    Following FDA win, Portola loses CEO William Lis
    Following FDA win, Portola loses CEO William Lis

    https://endpts.com/following-fda-win-portola-loses-ceo-william-lis/

    Brittany Meiling ENDPTS
    04 Jun 2018
    Share Share
    Enforcement Report - Week of January 17, 2018
    Enforcement Report - Week of January 17, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf

    FDA
    17 Jan 2018
    Share Share
    Review of Lovenox and associated names
    Review of Lovenox and associated names

    http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Lovenox_and_associated_names/human_referral_000412.jsp&mid=WC0b01ac05805c516f

    EMA
    22 Mar 2017
    Share Share
    SEC targets biopharma tipster, hedge funders in insider trading suit
    SEC targets biopharma tipster, hedge funders in insider trading suit

    http://www.fiercepharma.com/pharma/sec-sweeps-up-another-biopharma-tipster-for-insider-trading

    Tracy Staton FIERCE PHARMA
    16 Jun 2016
    Share Share
    Big Pharma's cardiovascular sales ain't what they used to be
    Big Pharma's cardiovascular sales ain't what they used to be

    http://www.fiercepharma.com/story/big-pharmas-cardiovascular-sales-aint-what-they-used-be/2015-05-07

     Emily Wasserman FIERCE PHARMA
    07 May 2015
    Share Share
    Sanofi recalls Enoxaparin Sodium injections in UK
    Sanofi recalls Enoxaparin Sodium injections in UK

    https://www.gov.uk/drug-device-alerts?keywords=&alert_type%5B%5D=company-led-drugs&issued_date%5Bfrom%5D=&issued_date%5Bto%5D=

    GOV.UK
    03 Apr 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Suanfarma Enoxaparin Sodium

    Access Virtual Booth

    Contact Supplier

    View Presentation

    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search